Clinical Trials Logo

Seach Results for — “aids”

Smoking Cessation Intervention for Women Living With HIV - SoCIWHIV

Smoking Cessation Intervention for Women With HIV/AIDS

As people with HIV/AIDS live longer, the burden of non-AIDS-related health problems such as cardiovascular diseases and cancers on these people have consistently increased. Smoking is one of the major contributing factors to these health problems and rates of cigarette smoking in this group are substantially higher than those of the general population: 40-70% vs. 17-10%. Especially, women living with HIV/AIDS seem to be more susceptible to the negative consequence of smoking than their male counterparts. They are also less likely to see tobacco dependence treatment for dual stigma associated with both conditions: HIV infection and nicotine addiction. This is a pilot study to develop smoking cessation intervention for these women.

NCT02898597 — AIDS/HIV
Status: Completed
http://inclinicaltrials.com/aids-hiv/NCT02898597/

Efficacy of Glaucoma Drop Aids in Medication Compliance in the Patient Population at Boston Medical Center

Efficacy of Glaucoma Drop Aids in Medication Compliance in the Patient Population at Boston Medical Center

The purpose of this study is to determine whether glaucoma drop aids will be cost-effective in delivery of ophthalmic medications by improving medication compliance, visual function, and even decreasing medication waste in the patient population at Boston Medical Center (BMC).

NCT02867995 — Glaucoma
Status: Completed
http://inclinicaltrials.com/glaucoma/NCT02867995/

Clinical and Genomic Factors for Prognosis of AIDS Primary Effusion Lymphoma

Clinical and Genomic Factors for Prognosis of AIDS Primary Effusion Lymphoma

This research trial studies clinical factors and gene expression analysis for prognosis in tissue samples from patients with acquired immune deficiency syndrome (AIDS)-related primary effusion lymphoma. Gathering health information over time and studying samples of tissue from patients in the laboratory may help doctors learn about the prognosis of patients with AIDS-related primary effusion lymphoma.

NCT02823327 — AIDS-Related Primary Effusion Lymphoma
Status: Terminated
http://inclinicaltrials.com/aids-related-primary-effusion-lymphoma/NCT02823327/

Strength Training With Vascular Occlusion in Patients Harboring With HIV/Aids

Impact of Strength Training With Vascular Occlusion on the Syndrome Lipodystrophy in Patients Harboring With HIV/Aids

The use of antiretroviral therapy (ART) could prevent depression of the immune system of patients harboring with Human Immunodeficiency Virus (HIV), providing increased life expectancy, changing the classification of HIV / AIDS into a chronic illness. However prolonged use of ARTincreases the prevalence of lipodystrophy syndrome (SL), characterized by inadequate distribution of body fat and changes in lipid profile, associated with a significantly increased cardiovascular risk, among others. The practice of strength training (ST) helps in controlling SL, providing improved lipid profile and the quality of life of these patients. However, due to increased cardiovascular risk and physical weakness resulting from SL, the ST with vascular occlusion (STOV) could be a viable alternative training, to use low load (10-30% of maximal work capacity) with similar benefits ST traditional (STT), as already proven in other populations. The STOV is justified by the lower neuromuscular overhead, increasing the number of patients able to participate in this complementary therapy. The objective was to assess the impact of the combined strength training with vascular occlusion on SL and the skeletal muscle tissue in people harboring with HIV/Aids.

NCT02783417 — Cardiovascular Diseases
Status: Terminated
http://inclinicaltrials.com/cardiovascular-diseases/NCT02783417/

Clinical Trial of Recombinant Adenovirus Type 5 AIDS Vaccine

Phase I Clinical Trial of Recombinant Adenovirus Type 5 Therapeutic AIDS Vaccine Expressing Gag

This is a randomized, double-blind placebo-controlled dose-escalation clinical trial to evaluate the safety and the immunogenicity of Adenoviral vector 5 HIV-1 vaccines in subjects receiving stable highly active antiretroviral therapy(HAART) .

NCT02762045 — Acquired Immunodeficiency Syndrome
Status: Recruiting
http://inclinicaltrials.com/acquired-immunodeficiency-syndrome/NCT02762045/

Quality Control of CE-Certified Phonak Hearing Aids - 2016_06

Quality Control of CE-Certified Phonak Hearing Aids

A methodical evaluation of new CE-labelled Phonak Hearing Systems is intended to be conducted on hard of hearing participants to grant quality control prior to product launch. The aim of the investigation series is to ensure zero-defect overall performance of the new hearing systems as well as maximum benefit for the participant with the devices in comparison to previously outstanding Phonak Hearing Systems and to equivalent competitor devices.

NCT02740036 — Hearing Loss
Status: Completed
http://inclinicaltrials.com/hearing-loss/NCT02740036/

Quality Control of CE-Certified Phonak Hearing Aids - 2015_03

Quality Control of CE-Certified Phonak Hearing Aids

Phonak Hearing Systems pass through different development and study stages. At an early stage, feasibility studies are conducted to investigate new algorithms, features and functions in an isolated manner.

NCT02740023 — Hearing Loss
Status: Completed
http://inclinicaltrials.com/hearing-loss/NCT02740023/

Overcoming Barriers to HIV/AIDS Care and ART Initiation - LINC

Overcoming Barriers to HIV/AIDS Care and ART Initiation

The study will evaluate interventions to improve engagement in HIV care following HIV diagnosis through a voluntary counseling and testing program. The specific aims are to (1) determine if a VCT-based intervention of CD4 count testing, alone or in combination with peer counseling, improves linkage to HIV/AIDS care; (2) assess the impact of the intervention on ART initiation. The study will recruit 450 HIV-positive individuals from VCTs and randomize a third to standard counseling and referral, a third to receive CD4 testing at the VCT with results return by phone after 1 weeks, and a third to receive the same CD4 testing combined with peer counseling. These combined investigations will create a comprehensive understanding of obstacles to appropriate HIV/AIDS care and result in new interventions to achieve measurable outcomes in applied settings.

NCT02718456 — Engagement in HIV Care
Status: Completed
http://inclinicaltrials.com/engagement-in-hiv-care/NCT02718456/

Evaluation of a Binaural Spatialization Method for Hearing Aids - BHA(L&S)

Evaluation of a Binaural Spatialization Method for Hearing Aids, in Terms of Speech Intelligibility, Speaker Localization and Subjective Preference.

This study investigates the possible benefits of using binaural spatialization techniques in digital wireless microphone systems for hearing aids. Speech intelligibility tests, speaker localization tests and preference tests are performed. The results of a diotic (current rendering) and a binaural (suggested rendering) rendering are compared.

NCT02693704 — Sensorineural Hearing Loss
Status: Completed
http://inclinicaltrials.com/sensorineural-hearing-loss/NCT02693704/

Peer Education Program for HIV/AIDS Related Sexual Behaviors of Secondary School Students

Impact of Peer Education Program on HIV/AIDS Related Sexual Behaviors of Secondary School Students in Rural Communities, India: a Quasi-experimental Study.

Worldwide, about 50% of all new cases of HIV occur in youth between age 15 and 24 years. Studies in various countries show that both out of school and in school adolescents and youth are engaged in risky sexual behaviors. Peer-based interventions have become a common method to effect important health-related behavior changes and address the HIV/AIDS pandemic. This study therefore aimed to evaluate the effectiveness of peer education in improving HIV knowledge, attitude, and preventive practices among in-school adolescents

NCT02665091 — HIV
Status: Completed
http://inclinicaltrials.com/hiv/NCT02665091/